Chronic Myeloproliferative Disorders Active Not Recruiting Phase 2 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02556931Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft MalignanciesTreatment